
James E. Goodley
Examiner (ID: 9465)
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2817 |
| Total Applications | 366 |
| Issued Applications | 300 |
| Pending Applications | 1 |
| Abandoned Applications | 65 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18158484
[patent_doc_number] => 20230025076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TRIARYL METHANE COMPOSITION, DYE COMPOSITION FOR OCULAR MEMBRANE DYEING
[patent_app_type] => utility
[patent_app_number] => 17/901072
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901072 | TRIARYL METHANE COMPOSITION, DYE COMPOSITION FOR OCULAR MEMBRANE DYEING | Aug 31, 2022 | Abandoned |
Array
(
[id] => 18080871
[patent_doc_number] => 20220406483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64
[patent_app_type] => utility
[patent_app_number] => 17/894874
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894874 | Purification process for the preparation of non-carrier added copper-64 | Aug 23, 2022 | Issued |
Array
(
[id] => 18724425
[patent_doc_number] => 20230338584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/892769
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892769 | NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS | Aug 21, 2022 | Abandoned |
Array
(
[id] => 19608061
[patent_doc_number] => 12156920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Double-labeled probe for molecular imaging and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/889655
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17993
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 569
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889655 | Double-labeled probe for molecular imaging and use thereof | Aug 16, 2022 | Issued |
Array
(
[id] => 18483718
[patent_doc_number] => 20230211021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS OF IMAGING AND DELIVERING THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/884751
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884751
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884751 | METHODS OF IMAGING AND DELIVERING THERAPEUTIC AGENTS | Aug 9, 2022 | Abandoned |
Array
(
[id] => 19855532
[patent_doc_number] => 12258355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Probes for imaging huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 17/881895
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 52992
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881895 | Probes for imaging huntingtin protein | Aug 4, 2022 | Issued |
Array
(
[id] => 20385479
[patent_doc_number] => 12485189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Functionalized nanoparticles and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/864671
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 19
[patent_no_of_words] => 19608
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864671 | Functionalized nanoparticles and methods of making and using same | Jul 13, 2022 | Issued |
Array
(
[id] => 18483719
[patent_doc_number] => 20230211022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
[patent_app_type] => utility
[patent_app_number] => 17/810956
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810956 | Radiotherapeutic and companion imaging agents to target MC1R | Jul 5, 2022 | Issued |
Array
(
[id] => 17996735
[patent_doc_number] => 11497822
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-15
[patent_title] => Stabilized compositions of radionuclides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/858859
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 47746
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858859 | Stabilized compositions of radionuclides and uses thereof | Jul 5, 2022 | Issued |
Array
(
[id] => 18792702
[patent_doc_number] => 11826436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Methods and kits for preparing radionuclide complexes
[patent_app_type] => utility
[patent_app_number] => 17/857990
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7145
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857990 | Methods and kits for preparing radionuclide complexes | Jul 4, 2022 | Issued |
Array
(
[id] => 18306278
[patent_doc_number] => 20230110178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Macrocyclic Chelators and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/810316
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810316 | Macrocyclic chelators and methods of use thereof | Jun 29, 2022 | Issued |
Array
(
[id] => 19564742
[patent_doc_number] => 12139503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
[patent_app_type] => utility
[patent_app_number] => 17/803382
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9301
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/803382 | Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof | Jun 8, 2022 | Issued |
Array
(
[id] => 17836523
[patent_doc_number] => 20220273828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => DOTMP KIT FORMULATIONS FOR RADIOISOTOPES
[patent_app_type] => utility
[patent_app_number] => 17/750333
[patent_app_country] => US
[patent_app_date] => 2022-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750333 | DOTMP kit formulations for radioisotopes | May 20, 2022 | Issued |
Array
(
[id] => 17928492
[patent_doc_number] => 20220323617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/734647
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734647 | TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF | May 1, 2022 | Pending |
Array
(
[id] => 19280076
[patent_doc_number] => 20240216549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => ENHANCEMENT OF TREATMENT WITH IMMUNOTHERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/556646
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556646 | ENHANCEMENT OF TREATMENT WITH IMMUNOTHERAPEUTIC AGENTS | Apr 19, 2022 | Pending |
Array
(
[id] => 17805968
[patent_doc_number] => 20220257803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SUPERPARAMAGNETIC GOLD NANOPARTICLE CLUSTER-PROTEIN NANOPARTICLE FUSION BODY FOR MAGNETIC RESONANCE IMAGING AND MAGNETIC THERMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/722727
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722727 | SUPERPARAMAGNETIC GOLD NANOPARTICLE CLUSTER-PROTEIN NANOPARTICLE FUSION BODY FOR MAGNETIC RESONANCE IMAGING AND MAGNETIC THERMOTHERAPY | Apr 17, 2022 | Abandoned |
Array
(
[id] => 18242516
[patent_doc_number] => 20230074827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE
[patent_app_type] => utility
[patent_app_number] => 17/709798
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709798 | CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE | Mar 30, 2022 | Pending |
Array
(
[id] => 18310230
[patent_doc_number] => 20230114130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/700913
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700913 | TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES | Mar 21, 2022 | Pending |
Array
(
[id] => 17895486
[patent_doc_number] => 20220305148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NATURAL CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/697426
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697426 | NATURAL CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES | Mar 16, 2022 | Abandoned |
Array
(
[id] => 19622973
[patent_doc_number] => 12161765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Compositions and methods for removing bio-synthetic nano-particles from bodily fluids
[patent_app_type] => utility
[patent_app_number] => 17/692289
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 2797
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692289 | Compositions and methods for removing bio-synthetic nano-particles from bodily fluids | Mar 10, 2022 | Issued |